Partner Content Partner Content SMi’s Biosimilars & Biobetters - Exclusive Interview with Dr... Biosimilars & Biobetters conference information
Partner Content Partner Content Exclusive Interview Released from Pharma TeamUp Cold Chain Distribution
Partner Content Partner Content Introducing SMi’s 5th conference on Drug Safety 2018 this Ju... Drug Safety London 2018
Partner Content Partner Content Six pharma firms to participate at Pharmaceutical Microbiolo... Pharmaceutical Microbiology West Coast Conference
Partner Content Partner Content Latest developments and breakthroughs in antibiotic resistan... The growing global threat of antimicrobial resistance, research strategies aiming to eliminate resistance, latest scientific advancements for tackling resistance, as well as potential novel candida
News argenx's Forte acquisition delivers coeliac trial win argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
